Journal Logo

Articles by John Chalmers

Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials

Wang, Nelson; Harris, Katie; Chalmers, John; More

Journal of Hypertension. 39(8):1689-1696, August 2021.

EFFECTS OF BLOOD PRESSURE-LOWERING ON CANCER RISK: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 300,000 PARTICIPANTS

Copland, Emma; Canoy, Dexter; Nazarzadeh, Milad; More

Journal of Hypertension. 39:e7, April 2021.

BLOOD PRESSURE-LOWERING, ANTIHYPERTENSIVE TREATMENT AND INCIDENT DIABETES

Nazarzadeh, Milad; Bidel, Zeinab; Canoy, Dexter; More

Journal of Hypertension. 39:e8-e9, April 2021.

STRATIFIED EFFECTS OF BLOOD PRESSURE-LOWERING TREATMENT ON LONG-TERM BLOOD PRESSURE: A META-ANALYSIS OF INDIVIDUAL-LEVEL DATA OF 334,219 PARTICIPANTS FROM 50 RANDOMIZED TRIALS

Canoy, Dexter; Copland, Emma; Ramakrishnan, Rema; More

Journal of Hypertension. 39:e53, April 2021.

Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial

Minhas, Jatinder S.; Wang, Xia; Lindley, Richard I.; More

Journal of Hypertension. 39(2):280-285, February 2021.

Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

Sharman, James E.; O’Brien, Eoin; Alpert, Bruce; More

Journal of Hypertension. 38(1):21-29, January 2020.

Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study

Carcel, Cheryl; Neal, Bruce; Oparil, Suzanne; More

Journal of Hypertension. 37(11):2216-2224, November 2019.

Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage

Wang, Xia; Sandset, Else C.; Moullaali, Tom J.; More

Journal of Hypertension. 37(7):1463-1466, July 2019.

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes

Zhang, Zeqin; Tremblay, Johanne; Raelson, John; More

Journal of Hypertension. 37(4):775-789, April 2019.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials

Salam, Abdul; Atkins, Emily; Sundström, Johan; More

Journal of Hypertension. 37(1):16-23, January 2019.

Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials

Atkins, Emily R.; Hirakawa, Yoichiro; Salam, Abdul; More

Journal of Hypertension. 35(6):1318-1325, June 2017.

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study

Hamet, Pavel; Haloui, Mounsif; Harvey, François; More

Journal of Hypertension. 35:S24-S32, May 2017.

OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY

Hamet, Pavel; Haloui, Mounsif; Harvey, François; More

Journal of Hypertension. 34:e58, September 2016.

YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES

Simon, Paul; Krajcoviechová, Aelna; Harvey, Francois; More

Journal of Hypertension. 34:e204, September 2016.

OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE

Anderson, Craig; Sato, Shoichiro; Delcourt, Candice; More

Journal of Hypertension. 34:e396-e397, September 2016.

Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension

Palatini, Paolo; Rosei, Enrico Agabiti; Casiglia, Edoardo; More

Journal of Hypertension. 34(5):813-821, May 2016.

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes

Hirakawa, Yoichiro; Arima, Hisatomi; Webster, Ruth; More

Journal of Hypertension. 34(4):781-787, April 2016.

Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension

Weber, Michael A.; Schiffrin, Ernesto L.; White, William B.; More

Journal of Hypertension. 32(1):3-15, January 2014.

68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL

Hata, Jun; Arima, Hisatomi; Rothwell, Peter M; More

Journal of Hypertension. 30:e21, September 2012.

70 17q21.31 CNV DOSE DEPENDENT EFFECT ON THE PREVALENCE OF HYPERTENSION AND DYSLIPIDEMIA COMORBIDITY

Ivanga, Mahine; Sandoval, Johanna; Idaghdour, Youssef; More

Journal of Hypertension. 30:e22, September 2012.

434 EARLIER BLOOD PRESSURE LOWERING AND GREATER ATTENUATION OF HAEMATOMA GROWTH IN ACUTE INTRACEREBRAL HAEMORRHAGE: INTERACT PILOT PHASE

Arima, Hisatomi; Huang, Yining; Wang, Ji Guang; More

Journal of Hypertension. 30:e129, September 2012.

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

Brugts, Jasper J; Isaacs, Aaron; de Maat, Moniek PM; More

Journal of Hypertension. 29(3):509-519, March 2011.

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

Czernichow, Sébastien; Zanchetti, Alberto; Turnbull, Fiona; More

Journal of Hypertension. 29(1):4-16, January 2011.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

Ninomiya, Toshiharu; Zoungas, Sophia; Neal, Bruce; More

Journal of Hypertension. 28(6):1141-1149, June 2010.

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Arima, Hisatomi; Anderson, Craig; Omae, Teruo; More

Journal of Hypertension. 28(2):395-400, February 2010.

Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence

Chalmers, John; Joshi, Rohina; Kengne, Andre Pascal; More

Journal of Hypertension. 26:S21-S27, September 2008.

Show: